Results International regularly hosts and attends events designed to help clients broaden both their understanding of major trends and issues

Selecting the right partner for growth: PE or Trade

Selecting the right partner for growth


The rapid rise in private equity investment in technology, marketing services and healthcare in recent years has provided a really interesting alternative to founders seeking to de-risk, accelerate growth and find the right partner for the next phase of their development. There are some material differences – and similarities – between selling to a trade buyer and partnering with private equity, and understanding how they differ and what each brings to the table, is key to making the right choice. We are bringing together a panel of successful entrepreneurs that have had experience with both private equity and trade, to share their insights on what to expect from each and how to choose the right partner for you.

The event is designed for entrepreneurs / CEOs / founders / business owners, and we will focus on sharing practical and hard-earned advice on the following:

  • Choosing between PE and Trade
  • What each one brings to the table
  • What to expect post-deal
  • Different investment horizons
  • Choosing the right partner
  • Preparation: differences between a PE vs Trade or dual-track process

You’ll have an opportunity to have your questions answered by an expert panel including…


Rachel Cunliffe, Former CFO, Avecto

Rachel brings a two-fold perspective to the panel having been the Chief Financial Officer of Avecto (now BeyondTrust), through both a PE process and subsequent sale to the US enterprise software vendor, Bomgar. Rachel joined Avecto in 2012, and helped to build it rapidly into a global leader in cybersecurity software. In 2015, the company raised $49 million from the US growth equity fund JMI Equity. Following this investment, Avecto continued its exceptional growth and was acquired by Bomgar in 2018.

Dennis O’Brien, Co-Founder and CEO, Lucid Group

Dennis co-founded Lucid, a multi-award winning specialist provider of strategic medical communications services to global pharmaceutical companies, in 2007.  Dennis and his co-founder grew the business to over 100 employees by mid-2017, and at that point secured a £11 million investment from one of the UK’s leading mid-market private equity investors, LDC, to support further growth and US expansion.  Dennis has continued to grow the business since the investment and has made a number of acquisitions of other companies.

Rob Wood, Co-Founder and CEO, STEM 

Rob Wood co-founded STEM Marketing (now STEM Healthcare) in 2007, building it into the leading global provider of marketing and medical audits to pharmaceutical companies, with operations across 35 countries in Europe, the Americas and Asia, and consistent year-on-year growth of over 30%. In 2016, Rob led the company through sale to trade buyer UDG Healthcare, an LSE-listed global leader in healthcare services, in a deal worth up to £84m. Rob has continued to lead and build STEM within UDG since the transaction.

Register now before our limited spaces fill.

Unfortunately we have reached total capacity for this event. Please contact us if you cannot register -

Get in Touch

Talking is a more rewarding experience than reading

If you would like to have an informal conversation about how we work, or simply to discuss the next stage of your company’s development, please contact us.

View Global Offices     SUBSCRIBE

Connect with us

Follow Results International on Twitter Follow Results International on LinkedIn

Your Nearest Office